Last reviewed · How we verify
somatropin - adult cohort (somatropin-adult-cohort)
At a glance
| Generic name | somatropin-adult-cohort |
|---|---|
| Sponsor | Pfizer |
| Drug class | Growth Hormone |
| Target | Growth Hormone Receptor |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| Annual revenue | 446 |
Approved indications
- Treatment of growth hormone deficiency in adults.
- Treatment of short bowel syndrome and failure to thrive in adults.
- Treatment of HIV-associated wasting in adults.
- Treatment of adult-onset growth hormone deficiency.
- Treatment of Turner syndrome in adults.
- Treatment of Prader-Willi syndrome in adults.
- Treatment of growth hormone deficiency in adults with a history of radiation therapy to the head.
- Treatment of growth hormone deficiency in adults with a history of pituitary surgery.
Common side effects
Drug interactions
- Insulin
- Oral anticoagulants
- Estrogen-containing products
- Immunosuppressants
- Thyroid hormones
- Corticosteroids
- Warfarin
- Anticonvulsants
- Beta-blockers
- Salicylates
- Thiazide diuretics
- ACE inhibitors
Key clinical trials
- Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (PHASE3)
- Versartis International Trial in Adults With Long-Acting Growth Hormone (PHASE2)
- Growth Hormone Use in Adults With Prader-Willi Syndrome (PHASE3)
- Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
- Observational Prospective Study on Patients Treated With Norditropin®
- Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| SEC EDGAR | Revenue + earnings |